oxamniquine has been researched along with Sensitivity and Specificity in 1 studies
Oxamniquine: An anthelmintic with schistosomicidal activity against Schistosoma mansoni, but not against other Schistosoma spp. Oxamniquine causes worms to shift from the mesenteric veins to the liver where the male worms are retained; the female worms return to the mesentery, but can no longer release eggs. (From Martindale, The Extra Pharmacopoeia, 31st ed, p121)
oxamniquine : A racemate comprising equimolar amounts of (R)- and (S)-oxamniquine. An anthelmintic, it is administered orally for the treatment of schistomiasis caused by Schistosoma mansoni (but not by other Schistosoma species); intramuscular administration is no longer used as it causes severe pain at the injection site.
{2-[(isopropylamino)methyl]-7-nitro-1,2,3,4-tetrahydroquinolin-6-yl}methanol : A member of the class of quinolines that is 1,2,3,4-tetrahydroquinoline which is substituted at positions 2, 6, and 7 by (isopropylamino)methyl, hydroxymethyl, and nitro groups, respectively.
Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the therapeutic efficacy of oxamniquine and praziquantel, the two most clinically important schistosomicide drugs, and to compare the accuracy of faecal examination with the accuracy of oogram in testing for Schistosoma mansoni infection." | 9.10 | Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial. ( Antunes, CM; Coelho, PM; da Cunha, AS; Ferrari, ML; Tavares, CA, 2003) |
| "To evaluate the therapeutic efficacy of oxamniquine and praziquantel, the two most clinically important schistosomicide drugs, and to compare the accuracy of faecal examination with the accuracy of oogram in testing for Schistosoma mansoni infection." | 5.10 | Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial. ( Antunes, CM; Coelho, PM; da Cunha, AS; Ferrari, ML; Tavares, CA, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferrari, ML | 1 |
| Coelho, PM | 1 |
| Antunes, CM | 1 |
| Tavares, CA | 1 |
| da Cunha, AS | 1 |
1 trial available for oxamniquine and Sensitivity and Specificity
| Article | Year |
|---|---|
Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial.
Topics: Adult; Animals; Brazil; Feces; Female; Humans; Male; Oxamniquine; Parasite Egg Count; Placebos; Praz | 2003 |